CL2007001499A1 - Citrate and tartrate salts of compounds derived from pyrrolidinaminoacetylpyrrolidinboronic acid, dpp-iv inhibitors; pharmaceutical composition comprising said compounds; method of preparation of these; solid form; pharmaceutical combination that includes them; useful in the treatment of diabetes - Google Patents

Citrate and tartrate salts of compounds derived from pyrrolidinaminoacetylpyrrolidinboronic acid, dpp-iv inhibitors; pharmaceutical composition comprising said compounds; method of preparation of these; solid form; pharmaceutical combination that includes them; useful in the treatment of diabetes

Info

Publication number
CL2007001499A1
CL2007001499A1 CL2007001499A CL2007001499A CL2007001499A1 CL 2007001499 A1 CL2007001499 A1 CL 2007001499A1 CL 2007001499 A CL2007001499 A CL 2007001499A CL 2007001499 A CL2007001499 A CL 2007001499A CL 2007001499 A1 CL2007001499 A1 CL 2007001499A1
Authority
CL
Chile
Prior art keywords
compounds
pyrrolidinaminoacetylpyrrolidinboronic
dpp
diabetes
citrate
Prior art date
Application number
CL2007001499A
Other languages
Spanish (es)
Inventor
Jeremy Kroll
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of CL2007001499A1 publication Critical patent/CL2007001499A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Uso de un antígeno de lawsonia intracellularis para la vacunación de un animal joven contra infecciones contra este microorganismo o un animal que tiene anticuerpos contra este microorganismo o que se ha expuesto a estos anticuerpos.Use of a lawsonia intracellularis antigen for the vaccination of a young animal against infections against this microorganism or an animal that has antibodies against this microorganism or has been exposed to these antibodies.

CL2007001499A 2006-05-25 2007-05-24 Citrate and tartrate salts of compounds derived from pyrrolidinaminoacetylpyrrolidinboronic acid, dpp-iv inhibitors; pharmaceutical composition comprising said compounds; method of preparation of these; solid form; pharmaceutical combination that includes them; useful in the treatment of diabetes CL2007001499A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80320706P 2006-05-25 2006-05-25

Publications (1)

Publication Number Publication Date
CL2007001499A1 true CL2007001499A1 (en) 2008-01-18

Family

ID=39722421

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2007001499A CL2007001499A1 (en) 2006-05-25 2007-05-24 Citrate and tartrate salts of compounds derived from pyrrolidinaminoacetylpyrrolidinboronic acid, dpp-iv inhibitors; pharmaceutical composition comprising said compounds; method of preparation of these; solid form; pharmaceutical combination that includes them; useful in the treatment of diabetes

Country Status (4)

Country Link
CN (1) CN101454020A (en)
AR (1) AR061201A1 (en)
CL (1) CL2007001499A1 (en)
TW (1) TW200815027A (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8102786A (en) * 1981-06-10 1983-01-03 Duphar Int Res METHOD FOR IMMUNIZING PIGS AGAINST AUJESZKY'S DISEASE

Also Published As

Publication number Publication date
TW200815027A (en) 2008-04-01
AR061201A1 (en) 2008-08-13
CN101454020A (en) 2009-06-10

Similar Documents

Publication Publication Date Title
CY1115751T1 (en) PHARMACEUTICAL COMBINATION 3- (3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL) -PHENOLIS AND AN ANTIPEXIL
EA201170772A1 (en) ORGANIC COMPOUNDS
CL2010000188A1 (en) A method for treating an infection in a subject comprising the administration of 9 - [(2,2-dimethyl-propylamino) -methyl] -minocycline or a salt thereof; pharmaceutical composition comprising said compound; and its use.
EA201490815A1 (en) ETHERACEPT COMPOSITIONS, STABILIZED BY AMINO ACIDS
AR063429A1 (en) ANTI-HTNFALFA CRISTALINOS ANTIBODIES
UY32062A (en) BETA-SECRETASA INHIBITORS
CY1115893T1 (en) ANTI-PREVENTIVE PYRAMIDINES AND THEIR USES
ES2488407T3 (en) Pharmaceutical preparation containing lipase of bacterial origin
CL2012001348A1 (en) Hemitartrate crystal salt of compound genz-112638, glucosylceramide synthetase inhibitor; pharmaceutical composition comprising it, and its use in the treatment of gaucher disease and fabry disease.
BRPI0715396B8 (en) method of producing a vaccine composition
EA201791850A1 (en) Boron-containing small molecules
BRPI0906478B8 (en) anti-nr10 antibody, its use and pharmaceutical composition comprising it
AR084285A1 (en) IMMUNOGENIC COMPOSITIONS
CL2008002076A1 (en) Compounds derived from substituted aryloxazoles; process for preparing said compounds; pharmaceutical composition comprising them; and its use to treat diabetes, metabolic syndrome, dyslipidemias, among other diseases.
CL2008001783A1 (en) Deoxycholic acid (dca); pharmaceutical composition comprising it; deoxycolic acid preparation process; intermediate compounds, useful in the preparation of a drug to remove fat deposits.
MX2008013619A (en) Augmentation of titer for vaccination in animals.
EA200970605A1 (en) MAPK / ERK KINAZ INHIBITORS
CL2012002422A1 (en) Method for treating active lupus arthritis which comprises administering the patient laquinimod or its sodium salt orally.
CY1109916T1 (en) Benzimidazolo-thiophene compounds as PLK inhibitors
DK201100184U1 (en) Method for immunizing an avian species
DE602006017724D1 (en) salicylic acid derivatives
CY1111367T1 (en) NEW PRODUCTS OF DIOMETIN, THEIR METHOD OF PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
AR079050A1 (en) BENZOIMIDAZOLIC COMPOUNDS AND THEIR USES
NO20084320L (en) Antibodies to EGFL7 and methods for their use
AR096705A1 (en) COMPOSITION THAT INCLUDES GLUTAMIC ACID-N, N-DIACETATE (GLDA), WATER AND ENZYME